Colombo, Dec 18 (Prensa Latina) Officials from Sri Lanka and Cuba expressed mutual interest in strengthening cooperation relations between the two countries in the pharmaceutical sphere, a diplomatic source stated on Friday.
Sri Lanka’s Pharmaceutical Production, Supply and Regulation State Minister Prof. Channa Jayasumana received Cuban Ambassador Juana Elena Ramos at the headquarters of that Ministry and both exchanged on the two island nations’ experiences in controlling Covid-19.
The Sri Lanka state minister was interested in the development of the Cuban vaccine candidates, after which he highlighted the high development achieved by the Caribbean country in the pharmaceutical and biotechnological research.
Prensa Latina agency recently informed that the Cuban vaccine candidate Soberana 02 to fight Covid-19 will soon begin phase II of clinical trials and is the first Latin American vaccine to advance to that stage.
Previously, Cuba had registered the vaccine candidate Soberana 01.
Abdala (CIGB-66) and Mambisa (CIGB-669) are two other Cuban vaccine candidates developed by the Havana-based Genetic Engineering and Biotechnology Center to fight Covid-19. The former will be injected and the latter will be administered nasally.